Literature DB >> 10400334

Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes.

T Takeuchi1, A Böttcher, C M Quezada, T J Meade, H B Gray.   

Abstract

Cobalt(III) Schiff base complexes have been shown to inhibit the replication of the ocular herpes virus. It is well known that these complexes have a high affinity for nitrogenous donors such as histidine residues, and it is possible that they bind to (and inhibit) an enzyme that is crucial to viral replication. In model studies, we have found that [Co(acacen)(NH3)2]+ is an effective irreversible inhibitor of thermolysin at millimolar concentrations; it also inhibits human alpha-thrombin. Axial ligand exchange with an active-site histidine is the proposed mechanism of inhibition. The activity of thermolysin and thrombin can be protected by binding a reversible inhibitor to the active site before addition of the cobalt(III) complex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400334     DOI: 10.1016/s0968-0896(98)00272-7

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  20 in total

1.  Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complex.

Authors:  Allison S Harney; Laura B Sole; Thomas J Meade
Journal:  J Biol Inorg Chem       Date:  2012-05-22       Impact factor: 3.358

2.  Spectroscopic elucidation of the inhibitory mechanism of Cys2His2 zinc finger transcription factors by cobalt(III) Schiff base complexes.

Authors:  Marie C Heffern; Josh W Kurutz; Thomas J Meade
Journal:  Chemistry       Date:  2013-11-06       Impact factor: 5.236

3.  DNA Binding, Cleavage and Antibacterial Activity of Mononuclear Cu(II), Ni(II) and Co(II) Complexes Derived from Novel Benzothiazole Schiff Bases.

Authors:  Narendrula Vamsikrishna; Marri Pradeep Kumar; Somapangu Tejaswi; Aveli Rambabu
Journal:  J Fluoresc       Date:  2016-05-11       Impact factor: 2.217

4.  Light-activated protein inhibition through photoinduced electron transfer of a ruthenium(II)-cobalt(III) bimetallic complex.

Authors:  Robert J Holbrook; David J Weinberg; Mark D Peterson; Emily A Weiss; Thomas J Meade
Journal:  J Am Chem Soc       Date:  2015-03-02       Impact factor: 15.419

5.  Physical properties, ligand substitution reactions, and biological activity of Co(iii)-Schiff base complexes.

Authors:  A Paden King; Hendryck A Gellineau; Samantha N MacMillan; Justin J Wilson
Journal:  Dalton Trans       Date:  2019-05-07       Impact factor: 4.390

6.  Specific inhibition of the transcription factor Ci by a cobalt(III) Schiff base-DNA conjugate.

Authors:  Ryan R Hurtado; Allison S Harney; Marie C Heffern; Robert J Holbrook; Robert A Holmgren; Thomas J Meade
Journal:  Mol Pharm       Date:  2012-01-20       Impact factor: 4.939

7.  Hybrid organic-inorganic inhibitors of a PDZ interaction that regulates the endocytic fate of CFTR.

Authors:  Rituparna Kundu; Patrick R Cushing; Brian V Popp; Yu Zhao; Dean R Madden; Zachary T Ball
Journal:  Angew Chem Int Ed Engl       Date:  2012-06-14       Impact factor: 15.336

8.  Axial ligand exchange of N-heterocyclic cobalt(III) Schiff base complexes: molecular structure and NMR solution dynamics.

Authors:  Lisa M Manus; Robert J Holbrook; Tulay A Atesin; Marie C Heffern; Allison S Harney; Amanda L Eckermann; Thomas J Meade
Journal:  Inorg Chem       Date:  2013-01-02       Impact factor: 5.165

9.  Rational design of [Co(acacen)L2]+ inhibitors of protein function.

Authors:  Lauren M Matosziuk; Robert J Holbrook; Lisa M Manus; Marie C Heffern; Mark A Ratner; Thomas J Meade
Journal:  Dalton Trans       Date:  2013-01-22       Impact factor: 4.390

10.  Tuning cobalt(III) Schiff base complexes as activated protein inhibitors.

Authors:  Marie C Heffern; Viktorie Reichova; Joseph L Coomes; Allison S Harney; Elizabeth A Bajema; Thomas J Meade
Journal:  Inorg Chem       Date:  2015-09-02       Impact factor: 5.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.